Literature DB >> 23769483

Outcome and life satisfaction of adults with myelomeningocele.

Heidi Cope1, Kelly McMahon, Elizabeth Heise, Sonja Eubanks, Melanie Garrett, Simon Gregory, Allison Ashley-Koch.   

Abstract

BACKGROUND: Myelomeningocele (MMC) commonly causes impairments in body structure and functions as well as cognitive disabilities that can have an adverse effect on adult life. Improved medical care has resulted in increased numbers of individuals with MMC surviving to adulthood, however little is known about the impact of MMC on the lives of adults age 25 years or older.
OBJECTIVE: To gain a better understanding of outcomes in education, employment, relationships, reproduction and life satisfaction of adults with MMC.
METHODS: A primarily quantitative multiple-choice questionnaire designed to capture outcomes in education, employment, relationships and reproduction, along with a previously validated life satisfaction checklist (LiSat-11), was completed by adults with MMC. Relationships between demographic variables, outcomes and life satisfaction were determined using cross tabulation analysis, logistic regression and linear regression.
RESULTS: Ninety adults with MMC, age 25-85 years (median age 32), reported a diverse range of outcomes in education, employment, relationships and reproduction. The most consistent variable associated with difficulty attaining adult milestones was hydrocephalus, the presence of which reduced the likelihood of living independently (p ≤ 0.001), having a partner (p = 0.003) and reproducing (p ≤ 0.001), but did not contribute to reduced life satisfaction.
CONCLUSIONS: Adults with MMC, especially those without hydrocephalus, can obtain gainful employment, live independently, form partner relationships and have children, and these achievements contribute to life satisfaction. While MMC does not affect overall reported life satisfaction for adults, attention should be paid to specific domains with less reported satisfaction.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23769483      PMCID: PMC3687213          DOI: 10.1016/j.dhjo.2012.12.003

Source DB:  PubMed          Journal:  Disabil Health J        ISSN: 1876-7583            Impact factor:   2.554


  44 in total

1.  Long-term outcome in open spina bifida.

Authors:  Pippa Oakeshott; Gillian M Hunt
Journal:  Br J Gen Pract       Date:  2003-08       Impact factor: 5.386

Review 2.  Embryology of myelomeningocele and anencephaly.

Authors:  Mark S Dias; Michael Partington
Journal:  Neurosurg Focus       Date:  2004-02-15       Impact factor: 4.047

3.  Life satisfaction of young adults with spina bifida.

Authors:  H A Barf; M W M Post; M Verhoef; A Jennekens-Schinkel; R H J M Gooskens; A J H Prevo
Journal:  Dev Med Child Neurol       Date:  2007-06       Impact factor: 5.449

4.  A randomized trial of prenatal versus postnatal repair of myelomeningocele.

Authors:  N Scott Adzick; Elizabeth A Thom; Catherine Y Spong; John W Brock; Pamela K Burrows; Mark P Johnson; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Leslie N Sutton; Nalin Gupta; Noel B Tulipan; Mary E D'Alton; Diana L Farmer
Journal:  N Engl J Med       Date:  2011-02-09       Impact factor: 91.245

5.  Reproductive understanding, sexual functioning and testosterone levels in men with spina bifida.

Authors:  R M Decter; P D Furness; T A Nguyen; M McGowan; C Laudermilch; A Telenko
Journal:  J Urol       Date:  1997-04       Impact factor: 7.450

6.  Educational career and predictors of type of education in young adults with spina bifida.

Authors:  H A Barf; M Verhoef; M W M Post; A Jennekens-Schinkel; R H J M Gooskens; R A Mullaart; A J H Prevo
Journal:  Int J Rehabil Res       Date:  2004-03       Impact factor: 1.479

Review 7.  Aging with a disability.

Authors:  Heidi Klingbeil; Heather R Baer; Pamela E Wilson
Journal:  Arch Phys Med Rehabil       Date:  2004-07       Impact factor: 3.966

8.  Restrictions in social participation of young adults with spina bifida.

Authors:  H A Barf; M W M Post; M Verhoef; A Jennekens-Schinkel; R H J M Gooskens; A J H Prevo
Journal:  Disabil Rehabil       Date:  2009       Impact factor: 3.033

Review 9.  Adult patients with spina bifida cystica: genetic counselling, pregnancy and delivery.

Authors:  C C Rietberg; D Lindhout
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1993-11       Impact factor: 2.435

10.  Lifestyle in adults aged 35 years who were born with open spina bifida: prospective cohort study.

Authors:  Gillian M Hunt; Pippa Oakeshott
Journal:  Cerebrospinal Fluid Res       Date:  2004-12-10
View more
  6 in total

Review 1.  Care for Adults with Spina Bifida: Current State and Future Directions.

Authors:  Shubhra Mukherjee; Jacqueline Pasulka
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017

2.  Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.

Authors:  Esther B Dupepe; Betsy Hopson; James M Johnston; Curtis J Rozzelle; W Jerry Oakes; Jeffrey P Blount; Brandon G Rocque
Journal:  Neurosurg Focus       Date:  2016-11       Impact factor: 4.047

3.  Myelomeningocele: need for long-time complex follow-up-an observational study.

Authors:  Thomas Bakketun; Nils Erik Gilhus; Tiina Rekand
Journal:  Scoliosis Spinal Disord       Date:  2019-03-08

4.  In utero myelomeningocele repair reduces intensification of inflammatory changes in the dura mater and the skin.

Authors:  Agnieszka Pastuszka; Janusz Bohosiewicz; Anita Olejek; Jacek Zamłyński; Ewa Horzelska; Tomasz Koszutski
Journal:  J Spinal Cord Med       Date:  2020-03-30       Impact factor: 1.985

Review 5.  Spina bifida.

Authors:  Andrew J Copp; N Scott Adzick; Lyn S Chitty; Jack M Fletcher; Grayson N Holmbeck; Gary M Shaw
Journal:  Nat Rev Dis Primers       Date:  2015-04-30       Impact factor: 52.329

6.  Surgical Outcomes after Myelomeningocele Repair in Lusaka, Zambia.

Authors:  Rebecca A Reynolds; Arnold Bhebhe; Roxanna M Garcia; Heidi Chen; Christopher M Bonfield; Sandi Lam; Kachinga Sichizya; Chevis Shannon
Journal:  World Neurosurg       Date:  2020-10-19       Impact factor: 2.104

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.